Standardized recommendations for the management of lobular neoplasia in core biopsy
specimens are not established. The aim of our study was to define morphologic features of …

There are no consensus guidelines for the management of lobular neoplasia diagnosed on
core biopsy as the highest risk factor for cancer. This study aimed to assess the risk of …

Context.—Both atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) have
traditionally been considered to be risk factors for the development of invasive carcinoma …

Core needle biopsy is the preferred technique for evaluating breast masses and abnormal
mammographic findings. The frequency of detection of noninvasive lobular lesions by core …

Background Lobular neoplasia (LN) represents a spectrum of atypical proliferative lesions,
including atypical lobular hyperplasia and lobular carcinoma-in-situ. The need for excision …

We evaluated the efficacy of using standard radiologic and histologic criteria to guide the
follow‐up of patients with lobular carcinoma in situ (LCIS), lobular neoplasia (LN), or atypical …

Background Lobular neoplasia (LN) includes atypical lobular hyperplasia (ALH) and lobular
carcinoma in situ (LCIS). LN often is an incidental finding on breast core needle biopsy …

Context.—Lobular neoplasia encompasses a spectrum of disease, including atypical lobular
hyperplasia and lobular carcinoma in situ. Although classic forms of lobular neoplasia are …

PURPOSE: To retrospectively determine frequency of invasive cancer or ductal carcinoma in
situ (DCIS) at excisional biopsy in women with atypical lobular hyperplasia (ALH) or lobular …

BACKGROUND Approximately 25% of all cases of atypical ductal hyperplasia (ADH)
diagnosed on core biopsy of the breast are associated with ductal carcinoma in situ (DCIS) …